Stockreport

Corcept's relacorilant GRADIENT trial misses primary endpoint [Yahoo! Finance]

Corcept Therapeutics Incorporated  (CORT) 
Last corcept therapeutics incorporated earnings: 2/20 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: corcept.com/investors
PDF The trial will be used alongside data from the earlier GRACE trial to support the company's new drug application (NDA) submission this quarter. However, it missed its p [Read more]